share_log

Johnson & Johnson Drug Combination Shows Positive Results in Lung Cancer Study

Johnson & Johnson Drug Combination Shows Positive Results in Lung Cancer Study

強生藥物組合在肺癌研究中顯示出積極的結果
WSJ ·  01/07 21:57

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論